Advertisement

Topics

CREDENCE Shifts Our Thinking About SGLT2 Inhibitors

05:21 EDT 14 Jun 2019 | Medscape

The CREDENCE trial allows us to start thinking of SGLT2 inhibitors as drugs for preserving renal function, independent of other parameters, says Anne Peters.
Medscape Diabetes & Endocrinology

Original Article: CREDENCE Shifts Our Thinking About SGLT2 Inhibitors

NEXT ARTICLE

More From BioPortfolio on "CREDENCE Shifts Our Thinking About SGLT2 Inhibitors"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Endocrinology
Diabetes Diabetes Endocrine Disorders Obesity Oxycontin Renal Disease Thyroid Disorders Endocrinology is the study of the endocrine glands and the hormones that they secrete (Oxford Medical Dictionary). There are several g...